Havih Envirosciences, a subsidiary of Maxwell Biosciences, has announced a strategic partnership with the Government of Andhra Pradesh to establish advanced pharmaceutical research and production capabilities in the state. The collaboration was formalised through an agreement with the Andhra Pradesh Centre for Advanced Research on Livestock Limited (APCARL) recently.
Under the agreement, APCARL will provide Havih access to advanced R&D laboratories and underground Biosafety Level 4 (BSL-4) biocontainment facilities at its Pulivendula campus in YSR Kadapa district. Havih will develop and supply next-generation anti-infective medicines for early use within Andhra Pradesh, with manufacturing and export centered in India.
"Havih's partnership with the Government of Andhra Pradesh and APCARL directly advances that vision by building India-owned biocontainment research, first-in-class drug innovation and export-ready pharmaceutical IP. This collaboration is an investment in India's scientists, engineers and future innovators - and a practical step toward India's leadership in global health security," said Scotch McClure, Chairman of Havih Envirosciences.
Through strategic collaborations with government research institutions and global technology partners, Havih is building a next-generation R&D and production ecosystem designed to deliver durable economic value, globally relevant IP and higher-skilled, higher-wage scientific employment for India's growing workforce.